PREVIOUS
✖
FDA’s Approval for Zurzuvae
August 24 , 2023
331 days
434
0
- The US Food and Drug Administration (FDA) has approved Zurzuvae (zuranolone) for the treatment of postpartum depression (PPD) in adults.
- PPD has far-reaching consequences on the lives of women who experience it.
- The disorder severely hampers their ability to return to normal functioning after pregnancy.
Leave a Reply
Your Comment is awaiting moderation.